{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:36:29Z","timestamp":1757622989783,"version":"3.44.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The antiretroviral regime emtricitabine\u2013tenofovir disoproxil fumarate (Truvada [Gilead Sciences]) is a type of pre-exposure prophylaxis (PrEP) therapy used for the prevention and management of HIV infections. This protection, however, cannot be applied to other sexually transmitted infections (STIs), with many studies observing an increase in STI rates among individuals using PrEP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A 24-year-old man who had recently started PrEP with emtricitabine\u2013tenofovir disoproxil fumarate was found to have a clinically significant elevation in syphilis total antibody count on STI screening, but his rapid plasma reagin (RPR) and Treponema pallidum particle agglutination (TP-PA) results remained negative. The patient was subsequently treated for a syphilis infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Post-treatment testing showed a negative syphilis total antibody result. The patient was suspected to have undergone treponemal antibody seroreversion, a rare but previously documented phenomenon following successful treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>This case highlights the possible effect of PrEP on the immune system, requiring closer surveillance to prevent acquisition of other STIs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmae114","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T13:44:25Z","timestamp":1743428665000},"page":"550-553","source":"Crossref","is-referenced-by-count":0,"title":["A 24-year-old man taking PrEP with unusual syphilis test results"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9662-6643","authenticated-orcid":false,"given":"Marika L","family":"Forsythe","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Chicago Pritzker School of Medicine , Chicago, IL ,","place":["US"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2303-0969","authenticated-orcid":false,"given":"Hong-Kee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Chicago Pritzker School of Medicine , Chicago, IL ,","place":["US"]},{"name":"Department of Pathology and Laboratory Medicine, Endeavor Health , Evanston, IL ,","place":["US"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"2025090821370690600_CIT0001","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/jac\/dkq447","article-title":"Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection","volume":"66","author":"Anderson","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"2025090821370690600_CIT0002","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nsb0897-601","article-title":"Structure of thymidylate kinase reveals the cause behind the limiting step in AZT activation","volume":"4","author":"Lavie","year":"1997","journal-title":"Nat Struct Biol."},{"key":"2025090821370690600_CIT0003","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.1074\/jbc.273.19.11491","article-title":"Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides","volume":"273","author":"Schneider","year":"1998","journal-title":"J Biol Chem."},{"key":"2025090821370690600_CIT0004","doi-asserted-by":"publisher","first-page":"100483","DOI":"10.1016\/j.lanepe.2022.100483","article-title":"Social and behavioural determinants of syphilis: modelling based on repeated cross-sectional surveys from 2010 and 2017 among 278,256 men who have sex with men in 31 European countries","volume":"22","author":"Mendez-Lopez","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2025090821370690600_CIT0005","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10461-018-2252-9","article-title":"Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting","volume":"23","author":"Monta\u00f1o","year":"2019","journal-title":"AIDS Behav."},{"key":"2025090821370690600_CIT0006","doi-asserted-by":"publisher","first-page":"e0268670","DOI":"10.1371\/journal.pone.0268670","article-title":"High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: a retrospective review in the French Dat\u2019AIDS cohort","volume":"17","author":"Lemmet","year":"2022","journal-title":"PLoS One."},{"key":"2025090821370690600_CIT0007","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/QAI.0000000000000529","article-title":"Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals","volume":"68","author":"Castillo-Mancilla","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2025090821370690600_CIT0008","doi-asserted-by":"publisher","first-page":"S345","DOI":"10.1086\/655973","article-title":"Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals","volume":"202","author":"Pancino","year":"2010","journal-title":"J Infect Dis."},{"key":"2025090821370690600_CIT0009","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1086\/655968","article-title":"HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors","volume":"202","author":"McLaren","year":"2010","journal-title":"J Infect Dis."},{"key":"2025090821370690600_CIT0010","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11904-012-0118-8","article-title":"HIV and inflammation: mechanisms and consequences","volume":"9","author":"Hunt","year":"2012","journal-title":"Curr HIV\/AIDS Rep."},{"key":"2025090821370690600_CIT0011","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12929-018-0490-9","article-title":"The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects","volume":"25","author":"Osuji","year":"2018","journal-title":"J Biomed Sci."},{"key":"2025090821370690600_CIT0012","doi-asserted-by":"publisher","first-page":"l4746","DOI":"10.1136\/bmj.l4746","article-title":"Syphilis","volume":"366","author":"O\u2019Byrne","year":"2019","journal-title":"BMJ"},{"key":"2025090821370690600_CIT0013","doi-asserted-by":"publisher","first-page":"S818","DOI":"10.1093\/cid\/civ714","article-title":"Management of adult syphilis: key questions to inform the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines","volume":"61","author":"Ghanem","year":"2015","journal-title":"Clin Infect Dis."},{"year":"2021","author":"Centers for Disease Control and Prevention","key":"2025090821370690600_CIT0014"},{"key":"2025090821370690600_CIT0015","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-114-12-1005","article-title":"Serologic response to treatment of infectious syphilis","volume":"114","author":"Romanowski","year":"1991","journal-title":"Ann Intern Med."},{"key":"2025090821370690600_CIT0016","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1258\/0956462961917249","article-title":"Treatment of syphilis with azithromycin","volume":"7","author":"Mashkilleyson","year":"1996","journal-title":"Int J STD AIDS."},{"key":"2025090821370690600_CIT0017","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/655832","article-title":"Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century","volume":"51","author":"Se\u00f1a","year":"2010","journal-title":"Clin Infect Dis."},{"key":"2025090821370690600_CIT0018","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/clinids\/21.6.1361","article-title":"Syphilis in adults: from Christopher Columbus to Sir Alexander Fleming to AIDS","volume":"21","author":"Tramont","year":"1995","journal-title":"Clin Infect Dis."},{"key":"2025090821370690600_CIT0019","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/sti.55.2.110","article-title":"Therapeutic effect of oral doxycycline on syphilis","volume":"55","author":"Onoda","year":"1979","journal-title":"Br J Vener Dis"},{"key":"2025090821370690600_CIT0020","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7301a1","article-title":"CDC Laboratory recommendations for syphilis testing, United States, 2024","volume":"73","author":"Papp","year":"2024","journal-title":"MMWR Recomm Rep."},{"volume-title":"Syphilis Total Antibody IFU","year":"2021","key":"2025090821370690600_CIT0021"},{"volume-title":"Rapid Plasma Reagin (RPR) IFU","year":"2015","key":"2025090821370690600_CIT0022"},{"volume-title":"Treponema Pallidum Particle Agglutination (TP-PA) Antibody IFU","year":"2024","key":"2025090821370690600_CIT0023"},{"volume-title":"LIAISON Treponema Assay Total Automation for Syphilis Testing","key":"2025090821370690600_CIT0024"},{"volume-title":"Trep-Sure Syphilis Antibody IFU","year":"2015","key":"2025090821370690600_CIT0025"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/5\/550\/62810438\/lmae114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/5\/550\/62810438\/lmae114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:37:19Z","timestamp":1757381839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/56\/5\/550\/8100385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,29]]},"published-print":{"date-parts":[[2025,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmae114","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"type":"print","value":"0007-5027"},{"type":"electronic","value":"1943-7730"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,3,29]]}}}